ropivacaine has been researched along with Liver Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, Y; Xin, Y; Yong, LZ | 1 |
| Essawy, FM; Hafez, HS; Hussein, NA; Kamel, HH; Khafagy, HF; Radwan, KG; Refaat, AI | 1 |
| Jokinen, MJ | 1 |
1 review(s) available for ropivacaine and Liver Diseases
| Article | Year |
|---|---|
The pharmacokinetics of ropivacaine in hepatic and renal insufficiency.
Topics: Amides; Anesthetics, Local; Animals; Humans; Liver Diseases; Renal Insufficiency; Ropivacaine | 2005 |
2 trial(s) available for ropivacaine and Liver Diseases
| Article | Year |
|---|---|
Efficacy of postoperative continuous wound infiltration with local anesthesia after open hepatectomy.
Topics: Adult; Amides; Anesthetics, Intravenous; Anesthetics, Local; Double-Blind Method; Female; Hepatectomy; Humans; Liver Diseases; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Ropivacaine; Sufentanil; Time Factors | 2014 |
Effect of general and epidural anesthesia on hemostasis and fibrinolysis in hepatic patients.
Topics: Adult; Amides; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Local; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemoglobins; Hemostasis; Humans; Isoflurane; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Platelet Count; Prothrombin Time; Ropivacaine; Thrombin Time; Time Factors; Tissue Plasminogen Activator; Urinary Bladder Calculi | 2010 |